title: Dose-response downregulation within the span of single interpulse intervals.
abstract: Pituitary ACTH drives adrenal glucocorticoid (cortisol) pulses via a time-delayed asymptotic dose-response process. To test the postulate that ACTH stimulates cortisol secretion dynamically (unequally during the initiation and termination of a cortisol secretory burst), a mathematical formalism was developed in which dose-response hysteretic shifts were allowed, but not required, within the time evolution of ACTH-cortisol pulse pairs. A dual-waveform deconvolution model was used to quantify cortisol secretion rates and reconstruct ACTH concentration profiles in 28 healthy adults previously sampled every 10 min for 24 h in the unstressed state (8,120 measurements). ACTH concentration-cortisol secretion dose-response functions were then estimated in each subject 1) without hysteresis (base model) and with allowances for possible hysteresis in 2) ACTH potency, 3) adrenal sensitivity, and 4) ACTH efficacy. Model residual error was 40% lower in the potency and sensitivity models and 20% lower in the efficacy model than in the base model (P < 0.001). Mean time shifts for inferable hysteretic inflection were model-independent, i.e., grand mean (95% confidence interval) 22 (12-39) min after the onset of a cortisol secretory burst. Half-maximally effective ACTH concentrations (EC(50)) differed before and after hysteretic inflection within individual pulses: 1) 9.4 and 54 ng/l in the potency model (P < 0.001) and 2) 8.9 and 123 ng/l in the sensitivity model (P < 0.001) compared with 16 ng/l in the no-hysteresis model (P < 0.001). In the efficacy-shift model, estimated maximal ACTH drive varied by 17-fold within cortisol secretory bursts (from 22 to 1.3 nmol.l(-1).min cortisol secretion(-1), P < 0.001). The collective results introduce the basis for modeling the dynamics of rapid, reversible physiological downregulation within the span of single interpulse intervals in vivo. This construct should have utility in parsing mechanisms of physiological regulation in other integrative systems.
authors.affiliation: Department of Statistics, University of Virginia, Charlottesville, Virginia, USA.
authors.forename: Daniel M
authors.initials: DM
authors.lastname: Keenan
authors.forename: Ferdinand
authors.initials: F
authors.lastname: Roelfsema
authors.forename: Johannes D
authors.initials: JD
authors.lastname: Veldhuis
mesh_terms: D000311:Adrenal Glands / Q000378:metabolism*; D000324:Adrenocorticotropic Hormone / Q000378:metabolism*; D000328:Adult; D015536:Down-Regulation; D005260:Female; D005938:Glucocorticoids / Q000378:metabolism; D006728:Hormones / Q000378:metabolism*; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism* / Q000502:physiology; D008954:Models, Biological
chemical_list: D005938:Glucocorticoids; D006728:Hormones; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone
references.citation: Endocr Rev. 2006 Apr;27(2):101-40
references.pmid: 16434512
references.citation: J Clin Endocrinol Metab. 1998 Feb;83(2):688-92
references.pmid: 9467594
references.citation: Vitam Horm. 2005;70:265-79
references.pmid: 15727807
references.citation: Peptides. 2009 Aug;30(8):1448-55
references.pmid: 19416745
references.citation: Proc Natl Acad Sci U S A. 1989 Jul;86(13):4978-81
references.pmid: 2544885
references.citation: Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4028-33
references.pmid: 11274427
references.citation: Biochem Biophys Res Commun. 1991 Apr 15;176(1):94-101
references.pmid: 1708253
references.citation: Peptides. 2000 Feb;21(2):309-24
references.pmid: 10764961
references.citation: Horm Metab Res. 1998 Jun-Jul;30(6-7):311-4
references.pmid: 9694555
references.citation: Am J Physiol Regul Integr Comp Physiol. 2003 Nov;285(5):R950-61
references.pmid: 12842865
references.citation: Endocr Rev. 2008 Dec;29(7):823-64
references.pmid: 18940916
references.citation: Endocrinology. 2009 Apr;150(4):1941-51
references.pmid: 19022882
references.citation: Endocrinology. 1988 Dec;123(6):2605-10
references.pmid: 3197637
references.citation: Mol Cell Endocrinol. 2001 Feb 14;172(1-2):147-55
references.pmid: 11165048
references.citation: J Clin Invest. 1994 Apr;93(4):1828-33
references.pmid: 8163681
references.citation: Mol Cell Endocrinol. 1987 Aug;52(3):243-9
references.pmid: 2820814
references.citation: Endocrinology. 1996 Dec;137(12):5311-8
references.pmid: 8940351
references.citation: Endocrinology. 1998 Feb;139(2):443-50
references.pmid: 9449609
references.citation: Endocrinology. 1984 Mar;114(3):1041-7
references.pmid: 6365522
references.citation: Endocr Rev. 1988 Feb;9(1):3-37
references.pmid: 3286234
references.citation: Horm Metab Res. 2000 Jul;32(7):265-8
references.pmid: 10965931
references.citation: Endocrinology. 1989 Sep;125(3):1711-7
references.pmid: 2759041
references.citation: Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6740-5
references.pmid: 15090645
references.citation: Endocrinology. 1983 Jan;112(1):315-20
references.pmid: 6291918
references.citation: FEBS Lett. 1985 May 6;184(1):6-9
references.pmid: 2985448
references.citation: J Physiol. 1989 Sep;416:557-69
references.pmid: 2607463
references.citation: Endocrinology. 1990 Jul;127(1):218-26
references.pmid: 2163311
references.citation: Horm Metab Res. 1998 Jun-Jul;30(6-7):341-5
references.pmid: 9694560
references.citation: Mol Endocrinol. 1997 Apr;11(4):400-14
references.pmid: 9092792
references.citation: Life Sci. 1995;57(9):833-7
references.pmid: 7630311
references.citation: Mol Endocrinol. 2002 Dec;16(12):2746-53
references.pmid: 12456795
references.citation: Mol Pharmacol. 2003 Jul;64(1):132-42
references.pmid: 12815169
references.citation: Mol Cell Endocrinol. 1984 Jun;36(1-2):43-51
references.pmid: 6086424
references.citation: PLoS One. 2009 Oct 07;4(10):e7309
references.pmid: 19809495
references.citation: Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12795-800
references.pmid: 12237400
references.citation: Am J Physiol Endocrinol Metab. 2004 Oct;287(4):E652-61
references.pmid: 15186998